United States Peptides Market Report 2017

In this report, the United States Peptides market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Peptides in these regions, from 2012 to 2022 (forecast).

United States Peptides market competition by top manufacturers/players, with Peptides sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech (P) Limited

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Insulin
Teriparatide
Liraglutide
Leuprolide
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Peptides for each application, including
Diabetes
Infectious Diseases
Cancer
Osteoporosis

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Peptides Market Report 2017
1 Peptides Overview
1.1 Product Overview and Scope of Peptides
1.2 Classification of Peptides by Product Category
1.2.1 United States Peptides Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Peptides Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Insulin
1.2.4 Teriparatide
1.2.5 Liraglutide
1.2.6 Leuprolide
1.3 United States Peptides Market by Application/End Users
1.3.1 United States Peptides Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Cancer
1.3.5 Osteoporosis
1.4 United States Peptides Market by Region
1.4.1 United States Peptides Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Peptides Status and Prospect (2012-2022)
1.4.3 Southwest Peptides Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Peptides Status and Prospect (2012-2022)
1.4.5 New England Peptides Status and Prospect (2012-2022)
1.4.6 The South Peptides Status and Prospect (2012-2022)
1.4.7 The Midwest Peptides Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Peptides (2012-2022)
1.5.1 United States Peptides Sales and Growth Rate (2012-2022)
1.5.2 United States Peptides Revenue and Growth Rate (2012-2022)

2 United States Peptides Market Competition by Players/Suppliers
2.1 United States Peptides Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Peptides Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Peptides Average Price by Players/Suppliers (2012-2017)
2.4 United States Peptides Market Competitive Situation and Trends
2.4.1 United States Peptides Market Concentration Rate
2.4.2 United States Peptides Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Peptides Manufacturing Base Distribution, Sales Area, Product Type

3 United States Peptides Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Peptides Sales and Market Share by Region (2012-2017)
3.2 United States Peptides Revenue and Market Share by Region (2012-2017)
3.3 United States Peptides Price by Region (2012-2017)

4 United States Peptides Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Peptides Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Peptides Revenue and Market Share by Type (2012-2017)
4.3 United States Peptides Price by Type (2012-2017)
4.4 United States Peptides Sales Growth Rate by Type (2012-2017)

5 United States Peptides Sales (Volume) by Application (2012-2017)
5.1 United States Peptides Sales and Market Share by Application (2012-2017)
5.2 United States Peptides Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Peptides Players/Suppliers Profiles and Sales Data
6.1 Cipla Ltd.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Peptides Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Cipla Ltd. Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Emcure Pharmaceuticals Pvt. Ltd.
6.2.2 Peptides Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Gland Pharma Limited
6.3.2 Peptides Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Gland Pharma Limited Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Troikaa Pharmaceuticals Ltd.
6.4.2 Peptides Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Troikaa Pharmaceuticals Ltd. Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Biological E Limited
6.5.2 Peptides Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Biological E Limited Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bharat Biotech
6.6.2 Peptides Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bharat Biotech Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Samarth Life Sciences Pvt. Ltd.
6.7.2 Peptides Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Samarth Life Sciences Pvt. Ltd. Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 VHB Life Sciences Limited
6.8.2 Peptides Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 VHB Life Sciences Limited Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Celon Laboratories Pvt. Ltd.
6.9.2 Peptides Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Celon Laboratories Pvt. Ltd. Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 United Biotech (P) Limited
6.10.2 Peptides Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 United Biotech (P) Limited Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Peptides Manufacturing Cost Analysis
7.1 Peptides Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Peptides

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Peptides Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Peptides Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Peptides Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Peptides Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Peptides Sales Volume Forecast by Type (2017-2022)
11.3 United States Peptides Sales Volume Forecast by Application (2017-2022)
11.4 United States Peptides Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Peptides
Figure United States Peptides Market Size (K Units) by Type (2012-2022)
Figure United States Peptides Sales Volume Market Share by Type (Product Category) in 2016
Figure Insulin Product Picture
Figure Teriparatide Product Picture
Figure Liraglutide Product Picture
Figure Leuprolide Product Picture
Figure United States Peptides Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Peptides by Application in 2016
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Osteoporosis Examples
Table Key Downstream Customer in Osteoporosis
Figure United States Peptides Market Size (Million USD) by Region (2012-2022)
Figure The West Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Peptides Sales (K Units) and Growth Rate (2012-2022)
Figure United States Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Peptides Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Peptides Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Peptides Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Peptides Sales Share by Players/Suppliers
Figure 2017 United States Peptides Sales Share by Players/Suppliers
Figure United States Peptides Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Peptides Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Peptides Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Peptides Revenue Share by Players/Suppliers
Figure 2017 United States Peptides Revenue Share by Players/Suppliers
Table United States Market Peptides Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Peptides Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Peptides Market Share of Top 3 Players/Suppliers
Figure United States Peptides Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Peptides Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Peptides Product Category
Table United States Peptides Sales (K Units) by Region (2012-2017)
Table United States Peptides Sales Share by Region (2012-2017)
Figure United States Peptides Sales Share by Region (2012-2017)
Figure United States Peptides Sales Market Share by Region in 2016
Table United States Peptides Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Peptides Revenue Share by Region (2012-2017)
Figure United States Peptides Revenue Market Share by Region (2012-2017)
Figure United States Peptides Revenue Market Share by Region in 2016
Table United States Peptides Price (USD/Unit) by Region (2012-2017)
Table United States Peptides Sales (K Units) by Type (2012-2017)
Table United States Peptides Sales Share by Type (2012-2017)
Figure United States Peptides Sales Share by Type (2012-2017)
Figure United States Peptides Sales Market Share by Type in 2016
Table United States Peptides Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Peptides Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Peptides by Type (2012-2017)
Figure Revenue Market Share of Peptides by Type in 2016
Table United States Peptides Price (USD/Unit) by Types (2012-2017)
Figure United States Peptides Sales Growth Rate by Type (2012-2017)
Table United States Peptides Sales (K Units) by Application (2012-2017)
Table United States Peptides Sales Market Share by Application (2012-2017)
Figure United States Peptides Sales Market Share by Application (2012-2017)
Figure United States Peptides Sales Market Share by Application in 2016
Table United States Peptides Sales Growth Rate by Application (2012-2017)
Figure United States Peptides Sales Growth Rate by Application (2012-2017)
Table Cipla Ltd. Basic Information List
Table Cipla Ltd. Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cipla Ltd. Peptides Sales Growth Rate (2012-2017)
Figure Cipla Ltd. Peptides Sales Market Share in United States (2012-2017)
Figure Cipla Ltd. Peptides Revenue Market Share in United States (2012-2017)
Table Emcure Pharmaceuticals Pvt. Ltd. Basic Information List
Table Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales Growth Rate (2012-2017)
Figure Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales Market Share in United States (2012-2017)
Figure Emcure Pharmaceuticals Pvt. Ltd. Peptides Revenue Market Share in United States (2012-2017)
Table Gland Pharma Limited Basic Information List
Table Gland Pharma Limited Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gland Pharma Limited Peptides Sales Growth Rate (2012-2017)
Figure Gland Pharma Limited Peptides Sales Market Share in United States (2012-2017)
Figure Gland Pharma Limited Peptides Revenue Market Share in United States (2012-2017)
Table Troikaa Pharmaceuticals Ltd. Basic Information List
Table Troikaa Pharmaceuticals Ltd. Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Troikaa Pharmaceuticals Ltd. Peptides Sales Growth Rate (2012-2017)
Figure Troikaa Pharmaceuticals Ltd. Peptides Sales Market Share in United States (2012-2017)
Figure Troikaa Pharmaceuticals Ltd. Peptides Revenue Market Share in United States (2012-2017)
Table Biological E Limited Basic Information List
Table Biological E Limited Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biological E Limited Peptides Sales Growth Rate (2012-2017)
Figure Biological E Limited Peptides Sales Market Share in United States (2012-2017)
Figure Biological E Limited Peptides Revenue Market Share in United States (2012-2017)
Table Bharat Biotech Basic Information List
Table Bharat Biotech Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bharat Biotech Peptides Sales Growth Rate (2012-2017)
Figure Bharat Biotech Peptides Sales Market Share in United States (2012-2017)
Figure Bharat Biotech Peptides Revenue Market Share in United States (2012-2017)
Table Samarth Life Sciences Pvt. Ltd. Basic Information List
Table Samarth Life Sciences Pvt. Ltd. Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Samarth Life Sciences Pvt. Ltd. Peptides Sales Growth Rate (2012-2017)
Figure Samarth Life Sciences Pvt. Ltd. Peptides Sales Market Share in United States (2012-2017)
Figure Samarth Life Sciences Pvt. Ltd. Peptides Revenue Market Share in United States (2012-2017)
Table VHB Life Sciences Limited Basic Information List
Table VHB Life Sciences Limited Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure VHB Life Sciences Limited Peptides Sales Growth Rate (2012-2017)
Figure VHB Life Sciences Limited Peptides Sales Market Share in United States (2012-2017)
Figure VHB Life Sciences Limited Peptides Revenue Market Share in United States (2012-2017)
Table Celon Laboratories Pvt. Ltd. Basic Information List
Table Celon Laboratories Pvt. Ltd. Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celon Laboratories Pvt. Ltd. Peptides Sales Growth Rate (2012-2017)
Figure Celon Laboratories Pvt. Ltd. Peptides Sales Market Share in United States (2012-2017)
Figure Celon Laboratories Pvt. Ltd. Peptides Revenue Market Share in United States (2012-2017)
Table United Biotech (P) Limited Basic Information List
Table United Biotech (P) Limited Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure United Biotech (P) Limited Peptides Sales Growth Rate (2012-2017)
Figure United Biotech (P) Limited Peptides Sales Market Share in United States (2012-2017)
Figure United Biotech (P) Limited Peptides Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptides
Figure Manufacturing Process Analysis of Peptides
Figure Peptides Industrial Chain Analysis
Table Raw Materials Sources of Peptides Major Players/Suppliers in 2016
Table Major Buyers of Peptides
Table Distributors/Traders List
Figure United States Peptides Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Peptides Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Peptides Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Peptides Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Peptides Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Peptides Sales Volume (K Units) Forecast by Type in 2022
Table United States Peptides Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Peptides Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Peptides Sales Volume (K Units) Forecast by Application in 2022
Table United States Peptides Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Peptides Sales Volume Share Forecast by Region (2017-2022)
Figure United States Peptides Sales Volume Share Forecast by Region (2017-2022)
Figure United States Peptides Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources